Related Experiment Video
Updated: Aug 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced
Stijn Heessen1, Ainars Leonchiks, Natalia Issaeva
1Microbiology and Tumor Biology Center, and Cancer Center Karolinska, Karolinska Institute, S-17177 Stockholm, Sweden.
Abstract:
Functional inactivation of the tumor suppressor protein p53 by accelerated ubiquitin/proteasome-dependent proteolysis is a common event in tumor progression. Proteasomal degradation is inhibited by the Gly-Ala repeat (GAr) of the Epstein-Barr virus nuclear antigen-1, which acts as a transferable element on a variety of proteasomal substrates. We demonstrate that p53 chimeras containing GAr domains of different lengths and positions within the protein are protected from proteolysis induced by the ubiquitin ligases murine double minute 2 and E6-associated protein but are still ubiquitinated and retain the capacity to interact with the S5a ubiquitin-binding subunit of the proteasome. The GAr chimeras transactivate p53 target genes, induce cell cycle arrest and apoptosis, and exhibit improved growth inhibitory activity in tumor cells with impaired endogenous p53 activity.
Insights
The Gly-Ala repeat (GAr) of Epstein-Barr virus nuclear antigen-1 protects the tumor suppressor p53 from degradation. This protection enhances p53
Area of Science:
- Molecular Biology
- Oncology
- Virology
Background:
- Tumor suppressor p53 inactivation via proteasomal degradation is common in cancer.
- Epstein-Barr virus nuclear antigen-1's Gly-Ala repeat (GAr) inhibits proteasomal degradation of various substrates.
Purpose of the Study:
- To investigate if the GAr can protect p53 from proteasomal degradation.
- To assess the functional consequences of GAr-mediated p53 stabilization.
Main Methods:
- Construction of p53 chimeras incorporating GAr domains.
- Assessment of p53 ubiquitination and proteasome interaction.
- Evaluation of p53 target gene transactivation, cell cycle arrest, and apoptosis induction.
Main Results:
- p53-GAr chimeras were protected from degradation by MDM2 and E6AP.
- Chimeras remained ubiquitinated and interacted with the proteasome's S5a subunit.
- GAr-stabilized p53 retained transactivation capacity, induced cell cycle arrest and apoptosis, and inhibited tumor cell growth.
Conclusions:
- The GAr domain can confer resistance to p53 proteasomal degradation.
- GAr-mediated stabilization of p53 preserves its tumor-suppressive functions.
- This strategy shows potential for enhancing anti-tumor activity in cancer therapy.
Related Concept Videos
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

